Post Title
LOREM IPSUM DOLOR SIT AMET

A Consortium led by aptaTargets has been awarded with public funding from the RETOS program for exploring new indications for ApTOLL, a DNA aptamer targeting TLR4 with an anti-inflammatory effect. The Consortium RETOS-SafeTOLL (RTC-2017-6283-1) is also composed by the Neurovascular Research Unit (Complutense University, Madrid) and the Institute of Biomedical Research (UAM-CSIC, Madrid) and has a total budget of 503,800 EU.

(FEDER/Ministerio de Ciencia, Innovación y Universidades – Agencia Estatal de Investigación/ _RTC-2017-6283-1)

Leave a comment